Voriconazole Articles
PDL BioPharma to pay MedImmune $92.5 million to resolve patent disputes; Mylan debuts generic Vfend
17 February 2011
China Sky One Medical’s Tianlong subsidiary to focus R&D efforts on antibiotics and cardiac drugs
22 January 2010
US FDA warns against use of PPI Prilosec with Plavix
18 November 2009
HalcyGen's SUBA-Itraconazole in commercial production
24 March 2008
Pfizer
23 July 2007
Cydex's Captisol drug gets Japanese appro
22 August 2005
Scotland OKs Xeloda but fears in England/Wales
15 August 2005
Pfizer to launch more products in India
27 April 2005
Pfizer's Vfend cleared by FDA for new use
24 November 2003
Benefits of Pfizer's voriconazole shown
12 August 2002
Pfizer antifungal drug cleared by EMEA
1 April 2002
Stock Commentary - New York
4 February 2002
CPMP backs Pfizer's Vfend
7 January 2002
CPMP backs Pfizer's Vfend
14 December 2001
Pfizer's Vfend nears US aproval
8 October 2001
FDA panel recommends Pfizer's Vfend
5 October 2001
Pfizer's Vfend on track for US approval?
4 October 2001
Merck & Co gets US approval for new antifungal agent Cancidas
30 January 2001
Stock Commentary - Tokyo
18 January 2001
US FDA panel backs approval of Merck & Co's antifungal Cancidas
17 January 2001
Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting
14 December 2000
Pfizer Aims For Top Slot After Millenium
10 November 1998
New Antifungals Highlighted At ICAAC
13 November 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
Zoloft Gets OCD Indication
4 November 1996
S-P Antifungals Promising
14 October 1996
Pfizer Presents Fertile Pipeline
6 November 1995
Showing 1-38 of 38 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
